Stock Price
0.26
Daily Change
-0.02 -5.45%
Monthly
-17.46%
Yearly
4.00%
Q3 Forecast
0.28

Paradigm Biopharmaceuticals reported AUD253.24M in Ordinary Share Capital for its fiscal semester ending in December of 2024.


Ordinary Share Capital Change Date
Medical Developments International AUD 115.01M 9.28M Dec/2024
Neuren Pharmaceuticals AUD 165.27M 10.43M Dec/2024
Pacific Edge NZD 294.46M 58K Sep/2024
PYC Therapeutics AUD 230.58M 0 Dec/2024
Telix Pharmaceuticals AUD 334.72M 252.68M Dec/2024